Praxis Precision Medicines (PRAX) Cash & Equivalents (2019 - 2026)
Praxis Precision Medicines (PRAX) posted Cash & Equivalents of $474.8 million for Q2 2026, down 11.48% on a QoQ basis from $536.3 million in Q1 2026, and up 201.6% year-over-year from $157.4 million in Q2 2025.
Powered by 
Analysis
Praxis Precision Medicines (PRAX) Cash & Equivalents (2019 - 2026) Analysis & Trends
Praxis Precision Medicines has reported Cash & Equivalents for 8 years, with the latest figure at $474.8 million in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 201.6% year-over-year to $474.8 million in Q2 2026; TTM through Jun 2026 was $474.8 million, a 201.6% increase from a year earlier, with the FY2025 full-year figure at $357.3 million, up 65.91% from the prior year.
- Cash & Equivalents was $474.8 million for Q2 2026 at Praxis Precision Medicines, down from $536.3 million in the prior quarter.
- The five-year high for Cash & Equivalents was $536.3 million in Q1 2026, with the low at $56.0 million in Q2 2022.
- Average Cash & Equivalents over 5 years is $176.0 million, with a median of $147.3 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Cash & Equivalents tumbled 68.14% in 2022, then soared 223.94% in 2026.
- Over 5 years, Cash & Equivalents stood at $61.6 million in 2022, then surged by 31.95% to $81.3 million in 2023, then soared by 164.91% to $215.4 million in 2024, then jumped by 65.91% to $357.3 million in 2025, then soared by 32.86% to $474.8 million in 2026.
- The last three Cash & Equivalents figures came in at $474.8 million (Q2 2026), $536.3 million (Q1 2026), and $357.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn | 6.14 Bn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn | 2.46 Bn |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn | 1.72 Bn |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | 3.58 Bn |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn | 1.25 Bn |
| 10 | Praxis Precision Medicines | 8.34 Bn | 7.58 Bn | - | 474.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 474.76 Mn |
| Mar 31, 2026 | 536.33 Mn |
| Dec 31, 2025 | 357.33 Mn |
| Sep 30, 2025 | 149.53 Mn |
| Jun 30, 2025 | 157.42 Mn |
| Mar 31, 2025 | 165.57 Mn |
| Dec 31, 2024 | 215.37 Mn |
| Sep 30, 2024 | 168.65 Mn |
| Jun 30, 2024 | 145.14 Mn |
| Mar 31, 2024 | 151.98 Mn |
| Dec 31, 2023 | 81.30 Mn |
| Sep 30, 2023 | 101.09 Mn |
| Jun 30, 2023 | 124.30 Mn |
| Mar 31, 2023 | 80.84 Mn |
| Dec 31, 2022 | 61.62 Mn |
| Sep 30, 2022 | 62.44 Mn |
| Jun 30, 2022 | 56.04 Mn |
| Mar 31, 2022 | 77.85 Mn |
| Dec 31, 2021 | 138.70 Mn |
| Sep 30, 2021 | 165.68 Mn |
API Access
Praxis Precision Medicines Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();